Paid Research Study

Psychedelic Clinical Study for Anxiety

Now enrolling new participants

Limited space remaining for participation - Earn up to $1983

Study Only available in English

 

FLL Now enrolling

Study Details

 

This study is evaluating the effectiveness of a one time investigational treatment for people with anxiety.

GAD landing page study details-1

 

Get Started 

 

Enter your information below to let our team know you're interested in participating in this Anxiety study

Exploring Psychedelic Research: A New Frontier in Mental Health

The Purpose Behind This Clinical Trial

Exploring Psychedelic Research: A New Frontier in Mental Health

Be Part of the Breakthrough: The Power of Participants

(FAQ) Frequently Asked Questions

You may qualify if you:

  • Are 18 to 65 years old

  • Have a clinical diagnosis of Generalized Anxiety Disorder (GAD)

  • Experience moderate to severe anxiety symptoms 

The study team will review your full health history and current medications to confirm eligibility.

This clinical research study is evaluating an investigational psychedelic-based therapy to explore whether it can help reduce symptoms of anxiety in people diagnosed with GAD.
Participants will receive two guided dosing sessions, along with preparation and integration therapy, as part of the study care experience.

If you qualify and enroll:

  • You'll attend several on-site visits for medical exams, therapy, and study dosing

  • Receive two doses of the study medication, spaced weeks apart

  • Complete follow-up visits for safety and wellbeing checks over a few months

All visits and procedures will be explained in detail by the study team.

Participation in this study is completely voluntary. You can withdraw at any time, for any reason, without any penalty or loss of benefits. Just let the study team know, and they will guide you through the process to ensure a safe and respectful exit from the study.

Paid Anxiety Research Study

What's Involved?

Get Signed Up

Enter your information and answer a few questions about yourself.

Participating 

If you qualify, a research doctor will review the study with you and answer any questions prior to joining!

Discussion

Research staff will reach out to ask a few questions about your medical history.

Special Access

Log in any time to access new studies, see what you've signed up for, and update your information.

Get Signed Up

Enter your information and answer a few questions about yourself.

Participating 

If you qualify, a research doctor will review the study with you and answer any questions prior to joining!

Discussion

Research staff will reach out to ask a few questions about your medical history.

Special Access

Log in any time to access new studies, see what you've signed up for, and update your information.

Challenges in living with anxiety

GAD is commonly treated with medications such as selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs). However, these treatments may not fully relieve anxiety symptoms for many individuals.

Current medications often fall short in addressing persistent worry and physical symptoms like restlessness, fatigue, and muscle tension — core features of GAD that continue to impact daily life even with treatment.